John H Baird (John Baird)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 21

Top Topics

Acute Lymphoblastic Leukemia

Functional Connectivity

Top Venues

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Esther H Nie, Yi-Jiun Su, John H Baird, Neha Agarwal, Sushma Bharadwaj, Wen-Kai Weng, Melody Smith, Saurabh Dahiya, May H Han, Jeffrey E Dunn, Lucas B Kipp, David Bernard Miklos, Brian J Scott, Matthew J Frank
Clinical features of neurotoxicity after CD19 CAR T-cell therapy in mantle cell lymphoma. Blood advances 8 (6) (2024)
Esther H Nie, Yi-Jiun Su, John H Baird, Neha Agarwal, Sushma Bharadwaj, Wen-Kai Weng, Melody Smith, Saurabh Dahiya, May H Han, Jeffrey E Dunn, Lucas B Kipp, David Bernard Miklos, Brian J Scott, Matthew J Frank
Clinical Features of Neurotoxicity Following CD19 CAR T-cell Therapy in Mantle Cell Lymphoma. Blood advances (2024)
James K Godfrey, Lei Gao, Geoffrey Shouse, Joo Y Song, Stacy Pak, Brian Lee, Bihong T Chen, Avyakta Kallam, John H Baird, Guido Marcucci, Lucy Ghoda, Stephanie Vauleon, Alexey V Danilov, Alex F Herrera, Larry W Kwak, L Elizabeth Elizabeth Budde
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma. Blood 144 (4) (2024)
Tamer Othman, John H Baird, Stacy Pak, Matthew G Mei, Alex F Herrera, Joshua Mansour, Geoffrey Shouse, Firoozeh Sahebi, Ricardo Spielberger, Ji-Lian Cai, Leonardo Farol, James Godfrey, Avyakta Kallam, Tycel Phillips, Leslie Popplewell, Tanya Siddiqi, Stephen Forman, L Elizabeth Elizabeth Budde
Real-world experience of axicabtagene ciloleucel, a CD19-directed CAR T-cell therapy, in the second-line treatment of early relapsed or primary refractory large B-cell lymphoma. British journal of haematology (2024)
James K Godfrey, Lei Gao, Geoffrey Shouse, Joo Y Song, Stacy Pak, Brian Lee, Bihong T Chen, Avyakta Kallam, John H Baird, Guido Marcucci, Lucy Ghoda, Stephanie Vauleon, Alexey V Danilov, Alex F Herrera, Larry W Kwak, L Elizabeth Elizabeth Budde
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma. Blood 144 (4) (2024)
James K Godfrey, Lei Gao, Geoffrey Shouse, Joo Y Song, Stacy Pak, Brian Lee, Bihong T Chen, Avyakta Kallam, John H Baird, Guido Marcucci, Lucy Ghoda, Stephanie Vauleon, Alexey V Danilov, Alex F Herrera, Larry W Kwak, L Elizabeth Elizabeth Budde
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma. Blood 144 (4) (2024)
James K Godfrey, Lei Gao, Geoffrey Shouse, Joo Y Song, Stacy Pak, Brian Lee, Bihong T Chen, Avyakta Kallam, John H Baird, Guido Marcucci, Lucy Y Ghoda, Stephanie Vauleon, Alexey V Danilov, Alex F Herrera, Larry W Kwak, L Elizabeth Elizabeth Budde
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma. Blood (2024)
James K Godfrey, Lei Gao, Geoffrey Shouse, Joo Y Song, Stacy Pak, Brian Lee, Bihong T Chen, Avyakta Kallam, John H Baird, Guido Marcucci, Lucy Ghoda, Stephanie Vauleon, Alexey V Danilov, Alex F Herrera, Larry W Kwak, L Elizabeth Elizabeth Budde
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma. Blood 144 (4) (2024)
James K Godfrey, Lei Gao, Geoffrey Shouse, Joo Y Song, Stacy Pak, Brian Lee, Bihong T Chen, Avyakta Kallam, John H Baird, Guido Marcucci, Lucy Y Ghoda, Stephanie Vauleon, Alexey V Danilov, Alex F Herrera, Larry W Kwak, L Elizabeth Elizabeth Budde
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma. Blood (2024)
Esther H Nie, Yi-Jiun Su, John H Baird, Neha Agarwal, Sushma Bharadwaj, Wen-Kai Weng, Melody Smith, Saurabh Dahiya, May H Han, Jeffrey E Dunn, Lucas B Kipp, David Bernard Miklos, Brian J Scott, Matthew J Frank
Clinical features of neurotoxicity after CD19 CAR T-cell therapy in mantle cell lymphoma. Blood advances 8 (6) (2024)
Tamer Othman, John H Baird, Stacy Pak, Matthew G Mei, Alex F Herrera, Joshua Mansour, Geoffrey Shouse, Firoozeh Sahebi, Ricardo Spielberger, Ji-Lian Cai, Leonardo Farol, James Godfrey, Avyakta Kallam, Tycel Phillips, Leslie Popplewell, Tanya Siddiqi, Stephen Forman, L Elizabeth Elizabeth Budde
Real-world experience of axicabtagene ciloleucel, a CD19-directed CAR T-cell therapy, in the second-line treatment of early relapsed or primary refractory large B-cell lymphoma. British journal of haematology 205 (1) (2024)
James K Godfrey, Lei Gao, Geoffrey Shouse, Joo Y Song, Stacy Pak, Brian Lee, Bihong T Chen, Avyakta Kallam, John H Baird, Guido Marcucci, Lucy Y Ghoda, Stephanie Vauleon, Alexey V Danilov, Alex F Herrera, Larry W Kwak, L Elizabeth Elizabeth Budde
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma. Blood (2024)
Shin Yeu Ong, John H Baird
A Primer on Chimeric Antigen Receptor T-cell Therapy-related Toxicities for the Intensivist. Journal of intensive care medicine (2023)
Colton Ladbury, Savita Dandapani, Claire Hao, Mildred Fabros, Arya Amini, Sagus Sampath, Scott Glaser, Karen Sokolov, Jekwon Yeh, John H Baird, Swetha Kambhampati, Alex Herrera, Matthew G Mei, Liana Nikolaenko, Geoffrey Shouse, Lihua E Budde
Long-Term Follow-Up of Bridging Therapies Prior to CAR T-Cell Therapy for Relapsed/Refractory Large B Cell Lymphoma. Cancers 15 (6) (2023)
Colton Ladbury, Savita Dandapani, Claire Hao, Mildred Fabros, Arya Amini, Sagus Sampath, Scott Glaser, Karen Sokolov, Jekwon Yeh, John H Baird, Swetha Kambhampati, Alex Herrera, Matthew G Mei, Liana Nikolaenko, Geoffrey Shouse, Lihua E Budde
Long-Term Follow-Up of Bridging Therapies Prior to CAR T-Cell Therapy for Relapsed/Refractory Large B Cell Lymphoma. Cancers 15 (6) (2023)
Shin Yeu Ong, Stacy Pak, Matthew G Mei, Yan Wang, Leslie Popplewell, John H Baird, Alex F Herrera, Geoffrey Shouse, Liana Nikolaenko, Jasmine M Zain, James Godfrey, Myo Htut, Ahmed Aribi, Ricardo Spielberger, Joshua Mansour, Stephen J Forman, Joycelynne Palmer, L Elizabeth Elizabeth Budde
Bendamustine lymphodepletion is a well-tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B-cell lymphoma. American journal of hematology (2023)
Michael Rainone, Dat Ngo, John H Baird, L Elizabeth Elizabeth Budde, Myo Htut, Ibrahim Aldoss, Vinod A Pullarkat
Interferon-γ blockade in CART-cell therapy-associated macrophage activation syndrome/hemophagocytic lymphohistiocytosis. Blood advances (2022)
Jay Y Spiegel, Shabnum Patel, Lori S Muffly, Nasheed M Hossain, Jean Oak, John H Baird, Matthew J Frank, Parveen Shiraz, Bita Sahaf, Juliana K Craig, Maria Iglesias, Sheren Younes, Yasodha Natkunam, Michael G Ozawa, Eric Yang, John Tamaresis, Harshini Chinnasamy, Zach Ehlinger, Warren Reynolds, Rachel Lynn, Maria Caterina Rotiroti, Nikolaos Gkitsas, Sally Arai, Laura Johnston, Robert Lowsky, Robbie G Majzner, Everett Meyer, Robert S Negrin, Andrew R Rezvani, Surbhi Sidana, Judith A Shizuru, Wen-Kai Weng, Chelsea Mullins, Allison Jacob, Ilan Kirsch, Magali Bazzano, Jing Zhou, Sean Mackay, Scott J Bornheimer, Liora Schultz, Sneha Ramakrishna, Kara L Davis, Katherine A Kong, Nirali N Shah, Haiying Qin, Terry J Fry, Steven Feldman, Crystal L Mackall, David Bernard Miklos
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial. Nature medicine 27 (8) (2021)
Andrew J Johnsrud, Juliana K Craig, John H Baird, Jay Spiegel, Lori S Muffly, James Zehnder, John S Tamaresis, Robert Negrin, Laura Johnston, Sally Arai, Judith Shizuru, Robert Lowsky, Everett Meyer, Wen-Kai Weng, Parveen Shiraz, Andrew Rezvani, Theresa Latchford, Crystal L Mackall, David Bernard Miklos, Matthew Frank, Surbhi Sidana
Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapy. Blood advances 5 (21) (2021)
Jason Gotlib, John H Baird, Tracy I George, Cheryl Langford, Isabel Reyes, Justin Abuel, Cecelia Perkins, Kurt Schroeder, Prithviraj Bose, Srdan Verstovsek
A phase 2 study of brentuximab vedotin in patients with CD30-positive advanced systemic mastocytosis. Blood advances 3 (15) (2020)
Karuna Dewan, John H Baird, Courtney Brooke Shires
An Unusual Cause of Epistaxis: Paranasal Sinus Myeloid Sarcoma. Case reports in hematology 2019 (2019)